May 6, 2020
Getinge Introduces Larger-Diameter Advanta V12 Balloon-Expandable Covered Stent to Treat Iliac Artery Disease
May 6, 2020—Getinge announced the commercial introduction of a larger-diameter Advanta V12 balloon-expandable covered stent, which expands from 12 to 16 mm, to treat iliac arterial occlusive disease. The larger-diameter Advanta V12 balloon-expandable covered stent has received European CE Mark and Australian TGA regulatory approvals for restoring and improving the patency of iliac arteries.
According to Getinge, the Advanta V12 stent is designed to restore iliac patency with reduced restenosis and reintervention rates, improved ankle-brachial index measurements, and sustained symptom relief. The device has 9-F compatibility for complex endovascular procedures.
The company reported that the first implantation of the Advanta V12 large-diameter stent was performed by Franklin Pond, MBBS, a vascular surgeon at the Western Hospital in Melbourne, Australia. In the company’s press release, he commented, “I am delighted to expand the treatment spectrum of patients receiving the new Advanta V12 large-diameter stent and pleased with the excellent angiographic outcome.”
Professor Michel Reijnen, MD, a vascular surgeon at the University of Twente in Enschede, the Netherlands, stated in Getinge’s announcement, “The trusted design of Advanta V12 is conformable, deliverable, and flexible to track through tortuous arteries and flex to accommodate the iliac arteries. It has the ability to postdilate up to 16 mm, providing customization to the patient’s anatomy.”
The Advanta V12 covered stent is also indicated for restoring and improving the patency of the renal arteries. Renal approval includes 5-, 6-, and 7-mm–diameter Advanta V12 sizes. In Canada, the Advanta V12 covered stent indication excludes renal arteries. The Advanta V12 stent is not available in the United States, advised the company.